Plea in Bombay High Court seeks information on safety, efficacy of COVID-19 vaccines; alleges violation of “right to know” by DCGI

Petitioner had filed an application under Section 7 of the RTI Act, which stipulates that requested information must be provided within 48 hours when it pertains to “life and liberty.” However, he received no response.
COVID-19 vaccine
COVID-19 vaccine

A petition has been filed in the Bombay High Court seeking directions to the Drug Controller General of India (DCGI) to furnish information submitted to it by Serum Institute of India (SII) and Bharat Biotech International (BBI) pertaining to the safety and efficacy of the COVID-19 vaccines that will be distributed by them.

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com